BioCentury
ARTICLE | Emerging Company Profile

Bringing CAR T to India

How Immuneel plans to bring a $50,000 CAR T treatment to India

August 3, 2019 12:06 AM UTC

A company formed this year in Bangalore by Kiran Mazumdar-Shaw, Kush Parmar and Siddhartha Mukherjee plans to bring a CAR T therapy to cancer patients in India for about $50,000 per treatment. That cost, which includes hospital and medical expenses, would be 20 to 40 times lower than that of CAR T treatments in the U.S.

Right now, CAR T isn’t available at any price in India, and some Indian patients have traveled to the U.S. and paid more than $1 million for the treatment. ...



Access The Full Article